Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+107.2%
5Y CAGR+558.5%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+107.2%/yr
vs +100.0%/yr prior
5Y CAGR
+558.5%/yr
Recent deceleration
Acceleration
+7.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
12378x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$24.76M+15.6%
2025$21.42M+874.1%
2024$-2.77M-199.4%
2023$2.78M-26.4%
2022$3.79M+189150.0%
2021$2000.000.0%
2020$2000.00-98.9%
2019$174000.00+7150.0%
2018$2400.000.0%
2017$2400.00-